Cell-Surface Receptors: EGFR- and VEGFR-Targeted Agents-Reference-Cited by-同舟云学术

Cell-Surface Receptors: EGFR- and VEGFR-Targeted Agents

Published:2022 Issue: Volume: Page:153-172
ISSN:
Container-title:Infectious Complications in Biologic and Targeted Therapies
language:
Short-container-title:

Author:

Aguilar-Company Juan^ORCID,Ruiz-Camps Isabel^ORCID

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-11363-5_8

Reference110 articles.

1. Krampera M, Pasini A, Rigo A, Scupoli MT, Tecchio C, Malpeli G, et al. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood. 2005;106:59–66.

2. Yamashita M, Chattopadhyay S, Fensterl V, Saikia P, Wetzel JL, Sen GC. Epidermal growth factor receptor is essential for toll-like receptor 3 signaling. Sci Signal. 2012;5:50.

3. Reinwald M, Boch T, Hofmann WK, Buchheidt D. Risk of infectious complications in hemato-oncological patients treated with kinase inhibitors. Biomark Insights. 2015;103:55–68.

4. Aguilar-Company J, Fernández-Ruiz M, García-Campelo R, Garrido-Castro AC, Ruiz-Camps I. ESCMID Study Group for infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (cell surface receptors and associated signaling pathways). Clin Microbiol Infect. 2018;24:S41–52.

5. Sharma SV, Bell DW, Settleman J, Haber DA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer. 2007;7:169–81.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer;Molecular Simulation;2023-09-15